| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |